Compare Paychex, Inc. (PAYX) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Paychex, Inc. vs Tilray Brands Inc — how do they compare? Paychex, Inc. trades at $103.98 (market cap $37.19B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Paychex, Inc. is far larger — about 70.1× Tilray Brands Inc's market cap, and Paychex, Inc. pays a 4.56% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Paychex, Inc. for 56 Days and Tilray Brands Inc for 31 Days on average.
| PAYX | TLRY | |
|---|---|---|
Market Cap | $37.19B | $530.54M |
Volume | 3,344,316 | 9,099,075 |
Sector | Industrials | Health |
52-Week High | $128.59 | $17.20 |
52-Week Low | $85.57 | $3.54 |
Typical Hold Time | 56 Days | 31 Days |
Enterprise Value | $40.87B | $684.46M |
Dividend Yield | 4.56% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Paychex (PAYX) trades at $104.46, up 2.87% on the day, showing resilience after recent volatility. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages, while fundamentals remain solid with consistent earnings beats, a 27.35% net income margin, and a forward P/E of 20.73. Recent news highlights strong Q1 2027 results but also concerns over dividend sustainability and labor market exposure.
The outlook is cautiously optimistic, supported by robust profitability and a consensus price target of $111, offering potential upside. Key risks include sensitivity to small business employment trends, high valuation multiples, and investor scrutiny of cash flow allocation. The stock presents a hold case for income-focused investors, balancing dividend yield against growth deceleration concerns.
TLRY trades at $3.59, down 3.36% on the day and near 52-week lows, with a bearish technical signal. The company reported revenue of $821.31M for 2025 but posted a net loss of -$2.19B, missing earnings expectations for four consecutive quarters. While analyst consensus shows 70% hold ratings, the stock faces significant profitability challenges with negative margins and cash flow concerns despite some revenue growth projections.
The outlook remains challenging with persistent losses and negative cash flow, though the stock trades at discounted valuation multiples. Key risks include ongoing profitability struggles and cannabis regulatory uncertainty. Potential catalysts include upcoming Q1 2027 earnings on October 8, 2026, and potential marijuana reform developments that could benefit the company's positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
